These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
589 related items for PubMed ID: 17984160
1. Reciprocal effects of combined administration of serotonin, noradrenaline and dopamine reuptake inhibitors on serotonin and dopamine levels in the rat prefrontal cortex: the role of 5-HT1A receptors. Weikop P, Kehr J, Scheel-Krüger J. J Psychopharmacol; 2007 Nov; 21(8):795-804. PubMed ID: 17984160 [Abstract] [Full Text] [Related]
2. The role of alpha1- and alpha2-adrenoreceptors on venlafaxine-induced elevation of extracellular serotonin, noradrenaline and dopamine levels in the rat prefrontal cortex and hippocampus. Weikop P, Kehr J, Scheel-Krüger J. J Psychopharmacol; 2004 Sep; 18(3):395-403. PubMed ID: 15358984 [Abstract] [Full Text] [Related]
3. Effects of venlafaxine on extracellular concentrations of 5-HT and noradrenaline in the rat frontal cortex: augmentation via 5-HT1A receptor antagonism. Dawson LA, Nguyen HQ, Geiger A. Neuropharmacology; 1999 Aug; 38(8):1153-63. PubMed ID: 10462128 [Abstract] [Full Text] [Related]
6. Comparison of effects of dual transporter inhibitors on monoamine transporters and extracellular levels in rats. Koch S, Hemrick-Luecke SK, Thompson LK, Evans DC, Threlkeld PG, Nelson DL, Perry KW, Bymaster FP. Neuropharmacology; 2003 Dec; 45(7):935-44. PubMed ID: 14573386 [Abstract] [Full Text] [Related]
7. Differential effects of adjunctive methylphenidate and citalopram on extracellular levels of serotonin, noradrenaline and dopamine in the rat brain. Weikop P, Yoshitake T, Kehr J. Eur Neuropsychopharmacol; 2007 Oct; 17(10):658-71. PubMed ID: 17383162 [Abstract] [Full Text] [Related]
8. Comparison of the effects of antidepressants on norepinephrine and serotonin concentrations in the rat frontal cortex: an in-vivo microdialysis study. Beyer CE, Boikess S, Luo B, Dawson LA. J Psychopharmacol; 2002 Dec; 16(4):297-304. PubMed ID: 12503828 [Abstract] [Full Text] [Related]
9. Effects of 5-HT(6) receptor blockade on the neurochemical outcome of antidepressant treatment in the frontal cortex of the rat. Dawson LA, Li P. J Neural Transm (Vienna); 2003 Jun; 110(6):577-90. PubMed ID: 12768354 [Abstract] [Full Text] [Related]
10. Triple reuptake inhibition of serotonin, norepinephrine, and dopamine increases the tonic activation of α2-adrenoceptors in the rat hippocampus and dopamine levels in the nucleus accumbens. Jiang JL, El Mansari M, Blier P. Prog Neuropsychopharmacol Biol Psychiatry; 2020 Dec 20; 103():109987. PubMed ID: 32474007 [Abstract] [Full Text] [Related]
11. Modulation of dialysate levels of dopamine, noradrenaline, and serotonin (5-HT) in the frontal cortex of freely-moving rats by (-)-pindolol alone and in association with 5-HT reuptake inhibitors: comparative roles of beta-adrenergic, 5-HT1A, and 5-HT1B receptors. Gobert A, Millan MJ. Neuropsychopharmacology; 1999 Aug 20; 21(2):268-84. PubMed ID: 10432475 [Abstract] [Full Text] [Related]
12. Effects of venlafaxine on extracellular 5-HT, dopamine and noradrenaline in the hippocampus and on peripheral hormone concentrations in the rat in vivo. Piacentini MF, Clinckers R, Meeusen R, Sarre S, Ebinger G, Michotte Y. Life Sci; 2003 Sep 26; 73(19):2433-42. PubMed ID: 12954452 [Abstract] [Full Text] [Related]
14. Effects of acute and chronic administration of atomoxetine and methylphenidate on extracellular levels of noradrenaline, dopamine and serotonin in the prefrontal cortex and striatum of mice. Koda K, Ago Y, Cong Y, Kita Y, Takuma K, Matsuda T. J Neurochem; 2010 Jul 26; 114(1):259-70. PubMed ID: 20403082 [Abstract] [Full Text] [Related]
15. Effects of sustained administration of the serotonin and norepinephrine reuptake inhibitor venlafaxine: I. in vivo electrophysiological studies in the rat. Béïque J, de Montigny C, Blier P, Debonnel G. Neuropharmacology; 2000 Jul 24; 39(10):1800-12. PubMed ID: 10884561 [Abstract] [Full Text] [Related]
16. Venlafaxine: discrepancy between in vivo 5-HT and NE reuptake blockade and affinity for reuptake sites. Béïque JC, de Montigny C, Blier P, Debonnel G. Synapse; 1999 Jun 01; 32(3):198-211. PubMed ID: 10340630 [Abstract] [Full Text] [Related]
17. Effect of citalopram, a selective serotonin reuptake inhibitor, on the acquisition of conditioned freezing. Inoue T, Hashimoto S, Tsuchiya K, Izumi T, Ohmori T, Koyama T. Eur J Pharmacol; 1996 Sep 05; 311(1):1-6. PubMed ID: 8884229 [Abstract] [Full Text] [Related]
18. S33005, a novel ligand at both serotonin and norepinephrine transporters: I. Receptor binding, electrophysiological, and neurochemical profile in comparison with venlafaxine, reboxetine, citalopram, and clomipramine. Millan MJ, Gobert A, Lejeune F, Newman-Tancredi A, Rivet JM, Auclair A, Peglion JL. J Pharmacol Exp Ther; 2001 Aug 05; 298(2):565-80. PubMed ID: 11454918 [Abstract] [Full Text] [Related]
19. Neurochemical evaluation of the novel 5-HT1A receptor partial agonist/serotonin reuptake inhibitor, vilazodone. Hughes ZA, Starr KR, Langmead CJ, Hill M, Bartoszyk GD, Hagan JJ, Middlemiss DN, Dawson LA. Eur J Pharmacol; 2005 Mar 07; 510(1-2):49-57. PubMed ID: 15740724 [Abstract] [Full Text] [Related]
20. Effects of selective serotonin and serotonin/noradrenaline reuptake inhibitors on extracellular serotonin in rat diencephalon and frontal cortex. Felton TM, Kang TB, Hjorth S, Auerbach SB. Naunyn Schmiedebergs Arch Pharmacol; 2003 Mar 07; 367(3):297-305. PubMed ID: 12644903 [Abstract] [Full Text] [Related] Page: [Next] [New Search]